Is Bristol-Myers Squibb Company Ce (CELG-RI) a Buy, Sell, or Hold?
Bristol-Myers Squibb Company Ce
NYSE:CELG-RI
$0.104 USD
$0.01 (13.04%)
- Volume
- 214
- Average Volume
- 39.59K
- Market Capitalization
- $212.38M
- P/E Ratio
- Dividend Yield
- %
- Price Target
- $
- Year High
- $0.10
- Year Low
- $0.10
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.23
Industry, Sector & symbol
| Stock Exchange | NYSE |
| CEO | Christopher S. Boerner |
| Industry | Drug Manufacturers - General |
| Sector | Healthcare |
| Current Symbol | CELG-RI |
| CUSIP | 110122140 |
| CIK | 0000014272 |
| Web | http://www.bms.com |
| Phone | +1 609 252 4000 |
| Currency | USD |
| Employees | 34100 |
| Country | US |
Liquidity
| Debt-to-Equity Ratio | 3.29 |
| Payout Ratio | 0.00 |
| Current Ratio | 2.23 |
| Quick Ratio | 2.12 |
| Cash Ratio | 1.04 |
Sales & Book Value
| Annual Sales | $15.28B |
| Price / Sales | 0.00 |
| Cash Flow | 6.60 |
| Price / Cash Flow | 0.00 |
| Price / Book | 0.00 |
Price Target and Rating
| Average Stock Price Forecast | $ |
| High Stock Price Forecast | $ |
| Low Stock Price Forecast | $ |
| Forecast Upside/Downside | % |
| Consensus Rating | Buy |
| Rating Score(0-5) | 4 |
| Research Coverage | 0 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $5.51 |
| Trailing P/E Ratio | |
| PEG Ratio | |
| P/E Growth | |
| Net Income | $4.05B |
| Net Margin | 26.48% |
| Pretax Margin | 31.62% |
| Return on Equity | 61.86% |
| Return on Assets | 11.40% |
Financials Score
| AltmanZ Score | 1.41 |
| Piotroski Score | 8.00 |
| Working Capital | 8.05B |
| Total Assets | 86.48B |
| Ebit | 11.4B |
| Market Cap | 181.74M |
| Total Liabilities | 66.37B |
Poll Results
About Bristol-Myers Squibb Company Ce (NYSE:CELG-RI) Stock
Bristol Myers Squibb Company (BMS) operates as a biopharmaceutical enterprise, managing the entire lifecycle of its therapeutic products, from initial discovery and development to manufacturing, marketing, and distribution. Its diverse portfolio includes conventional small molecule drugs, advanced biologics (which are derived from biological processes), and specialized chimeric antigen receptor (CAR-T) cell therapies. The company was established in August 1933 and maintains its corporate headquarters in Princeton, New Jersey. ...
Frequently Asked Questions
-
What is the current Bristol-Myers Squibb Company Ce (CELG-RI) stock price?
-
Bristol-Myers Squibb Company Ce(NYSE:CELG-RI) stock price is $0.104 in the last trading session. During the trading session, CELG-RI stock reached the peak price of $0.104 while $0.104 was the lowest point it dropped to. The percentage change in CELG-RI stock occurred in the recent session was 13.04% while the dollar amount for the price change in CELG-RI stock was $0.01.
-
CELG-RI's industry and sector of operation?
-
The NYSE listed CELG-RI is part of Drug Manufacturers - General industry that operates in the broader Healthcare sector.
-
Who are the executives of CELG-RI?
-
|
|
|
|
| -
How many employees does CELG-RI have?
-
Number of CELG-RI employees currently stands at 34100. CELG-RI operates from Route 206 & Province Line Road, Princeton, NJ 8543, US.
-
Link for CELG-RI official website?
-
Official Website of CELG-RI is: http://www.bms.com
-
How do I contact CELG-RI?
-
CELG-RI could be contacted at phone #+1 609 252 4000 and can also be accessed through its website. CELG-RI operates from Route 206 & Province Line Road, Princeton, NJ 8543, US.
-
How many shares of CELG-RI are traded daily?
-
The average number of CELG-RI shares traded daily for last 3 months was 39.59K.
-
What is the market cap of CELG-RI currently?
-
The market value of CELG-RI currently stands at $212.38M with its latest stock price at $0.104